- In April 2023, Thermo Fisher Scientific Inc. introduced its next-generation Multiskan SkyHigh Microplate Spectrophotometer, designed to support a broad range of absorbance-based applications in molecular biology, biochemistry, and drug discovery. This user-friendly, touchscreen-operated system enhances workflow efficiency in both research and clinical laboratories. The development demonstrates Thermo Fisher’s ongoing commitment to delivering high-performance analytical tools that cater to evolving laboratory needs across the globe
- In March 2023, Agilent Technologies Inc. announced the expansion of its BioTek product line with a new automated spectrophotometric plate reader tailored for high-throughput screening. The new model integrates seamlessly with robotic systems, enabling enhanced scalability for pharmaceutical and academic research. This advancement underscores Agilent’s dedication to innovation in analytical instrumentation, particularly for life science applications requiring speed, precision, and reproducibility
- In March 2023, BMG LABTECH GmbH launched the CLARIOstar Plus with Enhanced Dynamic Range (EDR), offering unmatched flexibility and sensitivity in absorbance measurements. The updated reader features patented dual optic systems and integrated software for real-time data analysis, further solidifying BMG LABTECH’s role as a leader in next-generation microplate reader technology
- In February 2023, PerkinElmer Inc. collaborated with a consortium of academic institutions to supply its EnVision Multimode Plate Readers for cancer biomarker research. The partnership aims to accelerate translational research and diagnostics through high-throughput spectrophotometric analysis. This initiative highlights PerkinElmer’s strategic focus on supporting life science research and personalized medicine development
- In January 2023, Tecan Group Ltd. unveiled updates to its Spark multimode plate reader, incorporating AI-driven protocols for absorbance assays. These improvements facilitate more intuitive data interpretation and enhanced assay reproducibility, particularly in clinical diagnostics and drug screening. The launch reflects Tecan’s strategic vision to fuse automation with intelligent software, making advanced spectrophotometric tools more accessible and impactful for laboratories worldwide
